However, it has been shown that patients with severe COVID-19 disease exhibit a higher expression of leukocyte PKM2, suggesting that increased PKM2 is involved in the metabolic reprogramming process participating in the immune response induced by COVID-19 [47]. Here, PKM is linked to COVID-19.